These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 19322209)
1. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Wojiski S; Guibal FC; Kindler T; Lee BH; Jesneck JL; Fabian A; Tenen DG; Gilliland DG Leukemia; 2009 Aug; 23(8):1462-71. PubMed ID: 19322209 [TBL] [Abstract][Full Text] [Related]
2. Understanding the molecular pathogenesis of acute promyelocytic leukemia. Lo-Coco F; Hasan SK Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding. Schoofs T; Rohde C; Hebestreit K; Klein HU; Göllner S; Schulze I; Lerdrup M; Dietrich N; Agrawal-Singh S; Witten A; Stoll M; Lengfelder E; Hofmann WK; Schlenke P; Büchner T; Hansen K; Berdel WE; Rosenbauer F; Dugas M; Müller-Tidow C Blood; 2013 Jan; 121(1):178-87. PubMed ID: 23152544 [TBL] [Abstract][Full Text] [Related]
4. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells. Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181 [TBL] [Abstract][Full Text] [Related]
5. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771 [TBL] [Abstract][Full Text] [Related]
6. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Westervelt P; Lane AA; Pollock JL; Oldfather K; Holt MS; Zimonjic DB; Popescu NC; DiPersio JF; Ley TJ Blood; 2003 Sep; 102(5):1857-65. PubMed ID: 12750176 [TBL] [Abstract][Full Text] [Related]
7. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation. Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929 [TBL] [Abstract][Full Text] [Related]
8. Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model. Santana BA; Pintão MC; Abreu e Lima RS; Scheucher PS; Santos GA; Garcia AB; Falcão RP; Rego EM Braz J Med Biol Res; 2006 May; 39(5):615-20. PubMed ID: 16648899 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752 [TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance. Zayed A; Couban S; Hayne O; Sparavalo N; Shawwa A; Sadek I; Greer W Leuk Lymphoma; 2007 Mar; 48(3):489-96. PubMed ID: 17454588 [TBL] [Abstract][Full Text] [Related]
12. Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting. Nasr R; de Thé H Int J Hematol; 2010 Jun; 91(5):742-7. PubMed ID: 20455087 [TBL] [Abstract][Full Text] [Related]
13. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Ding W; Li YP; Nobile LM; Grills G; Carrera I; Paietta E; Tallman MS; Wiernik PH; Gallagher RE Blood; 1998 Aug; 92(4):1172-83. PubMed ID: 9694705 [TBL] [Abstract][Full Text] [Related]
14. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Grisolano JL; Wesselschmidt RL; Pelicci PG; Ley TJ Blood; 1997 Jan; 89(2):376-87. PubMed ID: 9002938 [TBL] [Abstract][Full Text] [Related]
15. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Guibal FC; Alberich-Jorda M; Hirai H; Ebralidze A; Levantini E; Di Ruscio A; Zhang P; Santana-Lemos BA; Neuberg D; Wagers AJ; Rego EM; Tenen DG Blood; 2009 Dec; 114(27):5415-25. PubMed ID: 19797526 [TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell. Puccetti E; Ruthardt M Leukemia; 2004 Jul; 18(7):1169-75. PubMed ID: 15103387 [TBL] [Abstract][Full Text] [Related]